AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space. The company focuses on hereditary genetic illnesses, such as Ataxia Friedreich characterized by cardiac and central nervous system dysfunction. AavantiBio's mission is to leverage scientific expertise to serve unmet patients' needs.